Dipti Srivastava

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (23)

• Nanospanlastic delivery of repurposed rosuvastatin for augmented wound healing,Système de délivrance nanospanlastique de la rosuvastatine repositionnée pour l’amélioration de la cicatrisation des plaies
  Annales Pharmaceutiques Francaises 2026 DOI: 10.1016/j.pharma.2026.04.003
  +Save
• Spanlastics: Versatile Elastic Vesicles for Advanced Drug Delivery
  Drug Delivery Letters 2026 DOI: 10.2174/0122103031396470251113114021
  +Save
• Development and validation of a QbD-integrated sensitive RP-HPLC method for quantitation of fenofibrate: an application in quality control
  Analytical Methods 2026 DOI: 10.1039/d5ay01843a
  +Save
• A Comprehensive Review on Polyphenols based Nanovesicular System for Topical Delivery
  Current Drug Delivery 2025 DOI: 10.2174/0115672018265118231213094410
  +Save
• Box–behnken design based optimized Quercetin nano formulation for palliative treatment of atopic dermatitis
  Journal of Drug Delivery Science and Technology 2024 DOI: 10.1016/j.jddst.2024.106228
  +Save
• Crisaborole-Enthused Glycerosomal Gel for an Augmented Skin Permeation
  Recent Advances in Drug Delivery and Formulation 2024 DOI: 10.2174/0126673878283299240418112318
  +Save
• A Discursive Review of Recent Development and Patents on Glycerosomes
  Recent Patents on Nanotechnology 2023 DOI: 10.2174/1872210516666220328124450
  +Save
• Advances in semisolid dosage form
  Dosage Forms Formulation Developments and Regulations Recent and Future Trends in Pharmaceutics Volume 1 2023 DOI: 10.1016/B978-0-323-91817-6.00018-8
  +Save
• Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model
  Drug Development and Industrial Pharmacy 2023 DOI: 10.1080/03639045.2023.2244075
  +Save
• Glibenclamide–malonic acid cocrystal with an enhanced solubility and bioavailability
  Drug Development and Industrial Pharmacy 2022 DOI: 10.1080/03639045.2022.2122987
  +Save